Literature DB >> 26137097

DNA methyltransferase 3b silencing affects locus-specific DNA methylation and inhibits proliferation, migration and invasion in human hepatocellular carcinoma SMMC-7721 and BEL-7402 cells.

Jia-Chen Wang1, Zhao Wang1, Yu-Xia Fan1, Ya-Qing Si1, Jia-Xiang Wang1.   

Abstract

DNA methylation is an important regulator of gene transcription, and its role in carcinogenesis has been a topic of considerable interest in previous years. The present study examined the influence of DNA methyltransferase 3b (DNMT3b) on cell proliferation, migration and invasion, and the methylation status of identified tumor suppressor genes in hepatoma SMMC-7721 and BEL-7402 cells. DNMT3b was silenced by small interfering RNA (siRNA) in human hepatocellular carcinoma cell lines. Transfection efficiency was verified using a fluorescent imaging system, reverse transcription polymerase chain reaction (RT-PCR) and western blotting. A cell proliferation assay was performed to evaluate cell viability. Cell cycle distribution and apoptosis were analyzed by flow cytometry. The migratory and invasive ability of cells was measured using a Transwell assay. Methylation-specific PCR (MSP) was performed to assess methylation in the promoter region of genes. The present data revealed that DNMT3b siRNA successfully inhibited expression of the DNMT3b gene in these two liver cancer cell lines and therefore inhibited the proliferation of the transfected cells, stimulated apoptosis in the cells, led to an accumulation of cells in the G2/M phase and decreased cell migration and invasion. It was also found that silencing DNMT3b expression results in hypomethylation of specific sets of gene promoters and increases the expression of distinct set of genes in HCC cell lines. The present study is therefore useful for assessing the specificity of emerging action based on the altered expression of associated regulatory genes, particularly in methylation-silenced genes.

Entities:  

Keywords:  DNA mteyltransferase 3b; epigenetic; hepatocellular carcinoma cells; methylation; small interfering RNA

Year:  2015        PMID: 26137097      PMCID: PMC4473378          DOI: 10.3892/ol.2015.3077

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

1.  Genome-wide hypomethylation in hepatocellular carcinogenesis.

Authors:  C H Lin; S Y Hsieh; I S Sheen; W C Lee; T C Chen; W C Shyu; Y F Liaw
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

Review 2.  DNA methylation and human disease.

Authors:  Keith D Robertson
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

3.  The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention.

Authors:  W G Nelson; A M De Marzo; T L DeWeese
Journal:  Urology       Date:  2001-04       Impact factor: 2.649

4.  High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.

Authors:  Winnie Yeo; Nathalie Wong; Wai-Lap Wong; Paul B S Lai; Sheng Zhong; Philip J Johnson
Journal:  Liver Int       Date:  2005-04       Impact factor: 5.828

5.  Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.

Authors:  Marie-Pierre Lambert; Anupam Paliwal; Thomas Vaissière; Isabelle Chemin; Fabien Zoulim; Massimo Tommasino; Pierre Hainaut; Bakary Sylla; Jean-Yves Scoazec; Jörg Tost; Zdenko Herceg
Journal:  J Hepatol       Date:  2010-09-25       Impact factor: 25.083

6.  Identification of potential genes regulated by DNA methyltransferase 3B in a hepatocellular carcinoma cell line by RNA interference and microarray analysis.

Authors:  Jun Xu; Hong Fan; Zhu-Jiang Zhao; Jian-Qiong Zhang; Wei Xie
Journal:  Yi Chuan Xue Bao       Date:  2005-11

Review 7.  Altered methylation patterns in cancer cell genomes: cause or consequence?

Authors:  Stephen Baylin; Timothy H Bestor
Journal:  Cancer Cell       Date:  2002-05       Impact factor: 31.743

Review 8.  DNA methyltransferases, DNA damage repair, and cancer.

Authors:  Bilian Jin; Keith D Robertson
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 9.  MTSS1: a multifunctional protein and its role in cancer invasion and metastasis.

Authors:  Fei Xie; Lin Ye; Martin Ta; Lijian Zhang; Wen G Jiang
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

10.  MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.

Authors:  Jian Wang; Jingwu Li; Junling Shen; Chen Wang; Lili Yang; Xinwei Zhang
Journal:  BMC Cancer       Date:  2012-06-08       Impact factor: 4.430

View more
  5 in total

1.  Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins.

Authors:  Jiajie George Lu; Luan Nguyen; Sara Samadzadeh; Maryam Masouminia; Alejandro Mendoza; Owen Sweeney; Brittany Tillman; Nikoo Afifyan; Timothy Morgan; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2018-02-06       Impact factor: 3.362

2.  DNA methyltransferase 1, 3a, and 3b expression in hepatitis C associated human hepatocellular carcinoma and their clinicopathological association.

Authors:  Nadir Naveed Siddiqui; Ahtesham Ul Haq; Owais Ali Siddiqui; Rizma Khan
Journal:  Tumour Biol       Date:  2016-02-05

Review 3.  The Emerging Roles of Heterochromatin in Cell Migration.

Authors:  Gabi Gerlitz
Journal:  Front Cell Dev Biol       Date:  2020-05-27

4.  DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.

Authors:  Ssu-Chuan Lai; Yu-Ting Su; Ching-Chi Chi; Yung-Che Kuo; Kam-Fai Lee; Yu-Chih Wu; Pei-Chi Lan; Muh-Hwa Yang; Te-Sheng Chang; Yen-Hua Huang
Journal:  J Exp Clin Cancer Res       Date:  2019-11-26

5.  T-cell immunoglobulin mucin-3 as a potential inducer of the epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Huapeng Lin; Bin Yang; Mujian Teng
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.